Chiesi USA

Chiesi USA is owned by Chiesi. Chiesi has a direct presence in 12 countries.

Chiesi has 12 subsidiaries including Amryt Pharma, Chiesi Central Eastern Europe and Chiesi Czech Republic.

They are in:

• Pharmaceuticals92%
• Biotechnology8%

Acquisition, funding and merger involving Chiesi.

• Chiesi has announced the acquisition of Amryt Pharma  (posted on January 13 2023).

View the org chart displaying its 26 main executives

Most searched biographies at Chiesi USA

• Jon Zwinski, General Manager and Chief Executive Officer
• Michael Gordon, Vice President, Legal Affairs and General Counsel
• Carmen Dell'Anna, Head, Global Medical Excellence

Create your alert
to follow the executive moves at Chiesi USA.

Chiesi has 2,273 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Nurix Therapeutics has just announced a $175 Million fundraising (posted on April 13 2024).
• Nuvation Bio has announced the acquisition of AnHeart  (posted on April 12 2024).
• D3 Bio has just announced a $62 Million fundraising (posted on April 12 2024).

Popular contacts in Biotechnology

• Vik Bajaj - Director at Interline Therapeutics
• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Chiesi USA

Social media about Chiesi USA

• Chiesi USA on Wikipedia, Google News & Yahoo Finance
• Chiesi USA on LinkedIn, Twitter & YouTube

Contact by email its executives including Jon Zwinski

Call Chiesi USA at +1 888...

View the org chart

Register to receive your alert

Report an error